Science Explorer Back to mapMap
Discussion
Researcher · Nagasaki University · Japan

Takeshi Kitazaki

Takeshi Kitazaki publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Research Studies and Cancer therapeutics and mechanisms.

OpenAlex
World rank
#4,376,088
of 7,710,434 ranked researchers
Rank in Japan
#124,494
of 383,136
Works
68
Citations
1.7k
Citations per work
24.8
h-index
19
i10-index 27Top 21% in Pulmonary and Respiratory Medicine
Takeshi Kitazaki

What does Takeshi Kitazaki research?

Takeshi Kitazaki's work is mostly in Medicine (66%), Biochemistry, Genetics and Molecular Biology (11%).

Health Sciences: 45 works · 66.3% of their workMedicine: 45 works · 66.3% of their workPulmonary and Respiratory Medicine: 18 works · 27.0% of their workOncology: 15 works · 21.9% of their workEpidemiology: 6 works · 8.4% of their workSurgery: 3 works · 5.1% of their workNeurology: 3 works · 3.9% of their workEverything else: 15 works · 22.5% of their workLife Sciences: 8 works · 11.2% of their workBiochemistry, Genetics and Molecular Biology: 8 works · 11.2% of their workMolecular Biology: 8 works · 11.2% of their workTHEIR WORKTakeshi Kitazaki68works
Life Sciences11%Health Sciences66%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine4566.3%
  2. Everything else1522.5%
    1. Biochemistry, Genetics and Molecular Biology811.2%
  1. 1Pulmonary and Respiratory Medicine27% of their works
  2. 2Oncology22% of their works
  3. 3Molecular Biology11% of their works
  4. 4Epidemiology8% of their works
  5. 5Surgery5% of their works
  6. 6Neurology4% of their works

Research topics

Which keywords describe Takeshi Kitazaki's research?

The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Chemotherapy, ALK Inhibitors, EGFR Mutations, Immunotherapy, Genomic Profiles and Small-Cell Lung Cancer.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 20 words, with their numbers
  1. Clinical Trials442 topics
  2. Targeted Therapy442 topics
  3. Chemotherapy403 topics
  4. ALK Inhibitors241 topic
  5. EGFR Mutations241 topic
  6. Immunotherapy242 topics
  7. Genomic Profiles201 topic
  8. Small-Cell Lung Cancer201 topic
  9. CT Screening101 topic
  10. DNA101 topic
  11. Lung Cancer101 topic
  12. Topoisomerases101 topic
  13. ATP-dependent Transporters61 topic
  14. Multidrug Resistance61 topic
  15. BAP1 mutations41 topic
  16. Malignant Pleural Mesothelioma41 topic
  17. Neuroendocrine Tumors41 topic
  18. Pancreatic Neuroendocrine Tumors41 topic
  19. CD4731 topic
  20. apoptotic cells31 topic

Where does Takeshi Kitazaki work?

Takeshi Kitazaki's main affiliation in the publication record is Nagasaki University, Japan.

How many publications and citations does Takeshi Kitazaki have?

OpenAlex counts 68 works and 1,686 citations for Takeshi Kitazaki, an h-index of 19, ranking #4,376,088 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Takeshi Kitazaki. Posts are plain text and can be reported.